Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α | Journal of Translational Medicine | Full Text
Incidence and immunophenotype of abnormal lymphoblast populations at diagnosis of chronic myeloid leukaemia in chronic phase | SpringerLink
Cancers | Free Full-Text | CD26/DPP-4 in Chronic Myeloid Leukemia
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. - Abstract - Europe PMC